Abstract:Rationale: Cell reprogramming technology is utilized to prevent cancer progression by transforming cells into terminally differentiated, non-proliferating states. Polypyrimidine tract binding protein 1 (PTBP1) is an RNA binding protein required for the growth of neurons and may directly transform multiple normal human cells into functioning neurons in vitro and in vivo when expressed at low levels. As a result, we identified it as a key to inhibiting cancer cell proliferation by boosting glioblastoma cell neural differentiation. Methods: Immunocytofluorescence (ICF) targeting TUJ1, MAP2, KI67, and EdU were utilized to evaluate glioblastoma cell reprogramming under PTBP1 knockdown or other conditions. PTBP1 and other target genes were detected using Western blotting and qRT-PCR. Activating protein phosphatase 2A (PP2A) and RhoA were detected using specific kits. CCK8 assays were employed to detect cell viability. Bioluminescence, immunohistofluorescence (IHF), and Kaplan-Meier survival analyses were utilized to demonstrate the in vivo reprogramming efficiency of PTBP1 knockdown in U87 murine glioblastoma model. In this study, RNA-seq technology was used to examine the intrinsic pathway. Results: The expression of TUJ1 and MAP2 neural markers, as well as the absence of KI67 and EdU proliferative markers in U251, U87, and KNS89 cells, indicated that glioblastoma cell reprogramming was successful. In vivo, U87 growth generated xenografts was substantially shrank due to PTBP1 knockdown induced neural differentiation, and these tumor-bearing mice had a prolonged survival time. Following RNA-seq, ten potential downstream genes were eliminated. Lentiviral interference and inhibitors blocking tests demonstrated that UNC5B receptor and its downstream signaling were essential in the neural differentiation process mediated by PTBP1 knockdown in glioblastoma cells. Conclusions: Our results indicate that PTBP1 knockdown promotes neural differentiation of glioblastoma cells via UNC5B receptor, consequently suppressing cancer cell proliferation in vitro and in vivo, providing a promising and feasible approach for glioblastoma treatment.

Reducing Polypyrimidine Tract‑binding Protein 1 Fails to Promote Neuronal Transdifferentiation on HT22 and Mouse Astrocyte Cells under Physiological Conditions.

Downregulating PTBP1 Fails to Convert Astrocytes into Hippocampal Neurons and to Alleviate Symptoms in Alzheimer's Mouse Models.

Repressing PTBP1 Fails to Convert Reactive Astrocytes to Dopaminergic Neurons in a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease

Repressing PTBP1 is Incapable to Convert Reactive Astrocytes to Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease

Ptbp1 knockdown failed to induce astrocytes to neurons in vivo

Knockdown of Polypyrimidine Tract Binding Protein Facilitates Motor Function Recovery after Spinal Cord Injury.

Astroglial membrane camouflaged Ptbp1 siRNA delivery hinders glutamate homeostasis via SDH/Nrf2 pathway

PTBP1 knockdown promotes neural differentiation of glioblastoma cells through UNC5B receptor

Genetic loss of function of Ptbp1 does not induce glia-to-neuron conversion in retina

Myt1l induced direct reprogramming of pericytes into cholinergic neurons.

TET1 Deficiency Impairs Morphogen-free Differentiation of Human Embryonic Stem Cells to Neuroectoderm

Inhibition of neuronal phenotype by PTEN in PC12 cells

PTB: Not Just a Polypyrimidine Tract‐binding Protein

Polypyrimidine tract binding protein 1 regulates the activation of mouse CD8 T cells

Base editing of Ptbp1 in neurons alleviates symptoms in a mouse model for Parkinson's disease

Polypyrimidine tract binding protein knockdown reverses depression-like behaviors and cognition impairment in mice with lesioned cholinergic neurons

PTEN silencing enhances neuronal proliferation and differentiation by activating PI3K/Akt/GSK3β pathway in vitro

Direct Conversion of Fibroblasts to Neurons by Reprogramming PTB-Regulated MicroRNA Circuits

Expression of Pituitary Tumor Transforming Gene-1 Proto-Oncogene is Upregulated in the Brain of Neuronal-Specific Neural Salient Serine/Arginine Rich Protein-1 Gene Knockout Mice

The Protein Phosphatase Activity of PTEN is Essential for Regulating Neural Stem Cell Differentiation

PTBP1 as a potential regulator of disease